Purva Jain

724 total citations
27 papers, 501 citations indexed

About

Purva Jain is a scholar working on Cardiology and Cardiovascular Medicine, Health and Epidemiology. According to data from OpenAlex, Purva Jain has authored 27 papers receiving a total of 501 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Cardiology and Cardiovascular Medicine, 5 papers in Health and 5 papers in Epidemiology. Recurrent topics in Purva Jain's work include Atrial Fibrillation Management and Outcomes (5 papers), Health disparities and outcomes (5 papers) and Antiplatelet Therapy and Cardiovascular Diseases (4 papers). Purva Jain is often cited by papers focused on Atrial Fibrillation Management and Outcomes (5 papers), Health disparities and outcomes (5 papers) and Antiplatelet Therapy and Cardiovascular Diseases (4 papers). Purva Jain collaborates with scholars based in United States, United Kingdom and Canada. Purva Jain's co-authors include C. Michael Gibson, Serge Korjian, Yazan Daaboul, Roxana Mehran, Megan K. Yee, Ivana K. Kim, Anne Marie Lane, Douglas Arbetter, Evangelos S. Gragoudas and Gerald Chi and has published in prestigious journals such as Circulation, American Journal of Epidemiology and American Journal of Public Health.

In The Last Decade

Purva Jain

27 papers receiving 489 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Purva Jain United States 11 214 133 108 86 58 27 501
Mustafa Öztürk Türkiye 14 78 0.4× 61 0.5× 22 0.2× 51 0.6× 52 0.9× 33 540
Abdullah Alshehri Saudi Arabia 11 104 0.5× 103 0.8× 13 0.1× 74 0.9× 65 1.1× 49 393
Thomas Bo Jensen Denmark 15 166 0.8× 135 1.0× 65 0.6× 107 1.2× 60 1.0× 40 603
Bruce M. Psaty United States 9 134 0.6× 55 0.4× 52 0.5× 197 2.3× 65 1.1× 12 488
Irene Chung United Kingdom 13 443 2.1× 83 0.6× 189 1.8× 15 0.2× 67 1.2× 18 662
Þórarinn Guðnason Iceland 13 308 1.4× 140 1.1× 43 0.4× 26 0.3× 34 0.6× 27 549
Tarık Kıvrak Türkiye 7 157 0.7× 35 0.3× 27 0.3× 28 0.3× 21 0.4× 14 352
Khendi White Solaru United States 9 128 0.6× 295 2.2× 44 0.4× 86 1.0× 26 0.4× 22 468
Mohammad Keykhaei Iran 14 97 0.5× 65 0.5× 7 0.1× 17 0.2× 60 1.0× 45 516
KH Jöckel Germany 14 75 0.4× 65 0.5× 14 0.1× 75 0.9× 25 0.4× 28 529

Countries citing papers authored by Purva Jain

Since Specialization
Citations

This map shows the geographic impact of Purva Jain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Purva Jain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Purva Jain more than expected).

Fields of papers citing papers by Purva Jain

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Purva Jain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Purva Jain. The network helps show where Purva Jain may publish in the future.

Co-authorship network of co-authors of Purva Jain

This figure shows the co-authorship network connecting the top 25 collaborators of Purva Jain. A scholar is included among the top collaborators of Purva Jain based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Purva Jain. Purva Jain is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Marcum, Zachary A., et al.. (2024). Incidence of Herpes Zoster and Postherpetic Neuralgia and Herpes Zoster Vaccination Uptake in a US Administrative Claims Database. Open Forum Infectious Diseases. 11(5). ofae211–ofae211. 6 indexed citations
2.
Rider, Jennifer R., Asher Wasserman, Gillis Carrigan, et al.. (2024). Emulations of oncology trials using real-world data: a systematic literature review. American Journal of Epidemiology. 194(6). 1783–1793. 1 indexed citations
3.
Jain, Purva, et al.. (2024). Prevalence of Genital Herpes and Antiviral Treatment. Sexually Transmitted Diseases. 51(10). 686–693. 2 indexed citations
4.
Jain, Purva, et al.. (2023). Testing for Cytomegalovirus Among Individuals Who Were Immunocompromised, 2018-2022. JAMA Network Open. 6(11). e2345126–e2345126. 1 indexed citations
5.
Jain, Purva, Alexandra M. Binder, Brian Chen, et al.. (2022). Analysis of Epigenetic Age Acceleration and Healthy Longevity Among Older US Women. JAMA Network Open. 5(7). e2223285–e2223285. 38 indexed citations
6.
McEvoy, Linda K., Purva Jain, Candyce H. Kroenke, et al.. (2022). Association of Social Support with Mild Cognitive Impairment and Dementia Among Older Women: The Women’s Health Initiative Memory Study. Journal of Alzheimer s Disease. 91(3). 1107–1119. 6 indexed citations
7.
Jain, Purva, et al.. (2022). Relevance of Yama in Modern Times. International Journal of Advanced Research in Science Communication and Technology. 178–181. 1 indexed citations
8.
Bellettiere, John, et al.. (2021). Evaluation of Light Physical Activity Measured by Accelerometry and Mobility Disability During a 6-Year Follow-up in Older Women. JAMA Network Open. 4(2). e210005–e210005. 18 indexed citations
9.
Oren, Eyal, et al.. (2020). Twitter Communication During an Outbreak of Hepatitis A in San Diego, 2016–2018. American Journal of Public Health. 110(S3). S348–S355. 10 indexed citations
10.
Lane, Anne Marie, et al.. (2019). Conservative management of suspicious melanocytic lesions of the iris. Graefe s Archive for Clinical and Experimental Ophthalmology. 257(6). 1319–1324. 7 indexed citations
11.
Gibson, C. Michael, Serge Korjian, Gerald Chi, et al.. (2017). Comparison of Fatal or Irreversible Events With Extended‐Duration Betrixaban Versus Standard Dose Enoxaparin in Acutely Ill Medical Patients: An APEX Trial Substudy. Journal of the American Heart Association. 6(7). 34 indexed citations
12.
Arbetter, Douglas, Purva Jain, Megan K. Yee, et al.. (2017). Competing risk analysis in a large cardiovascular clinical trial: An APEX substudy. Pharmaceutical Statistics. 16(6). 445–450. 7 indexed citations
13.
Korjian, Serge, Eugene Braunwald, Yazan Daaboul, et al.. (2017). Safety and efficacy of rivaroxaban for the secondary prevention following acute coronary syndromes among biomarker-positive patients: Insights from the ATLAS ACS 2-TIMI 51 trial. European Heart Journal Acute Cardiovascular Care. 8(2). 186–193. 13 indexed citations
14.
15.
Kim, Ivana K., et al.. (2016). Ranibizumab for the Prevention of Radiation Complications in Patients Treated With Proton Beam Irradiation for Choroidal Melanoma (An American Ophthalmological Society Thesis). Europe PMC (PubMed Central). 114. 5 indexed citations
16.
Daaboul, Yazan, Serge Korjian, W. Douglas Weaver, et al.. (2016). Relation of Left Ventricular Mass and Infarct Size in Anterior Wall ST-Segment Elevation Acute Myocardial Infarction (from the EMBRACE STEMI Clinical Trial). The American Journal of Cardiology. 118(5). 625–631. 10 indexed citations
17.
Gibson, C. Michael, Gerald Chi, Rim Halaby, et al.. (2016). Extended-Duration Betrixaban Reduces the Risk of Stroke Versus Standard-Dose Enoxaparin Among Hospitalized Medically Ill Patients. Circulation. 135(7). 648–655. 50 indexed citations
18.
Gibson, C. Michael, Serge Korjian, Pierluigi Tricoci, et al.. (2016). Safety and Tolerability of CSL112, a Reconstituted, Infusible, Plasma-Derived Apolipoprotein A-I, After Acute Myocardial Infarction. Circulation. 134(24). 1918–1930. 144 indexed citations
19.
Kim, Ivana K., et al.. (2016). Ranibizumab for the Prevention of Radiation Complications in Patients Treated With Proton Beam Irradiation for Choroidal Melanoma.. PubMed. 114. T2–T2. 38 indexed citations
20.
Jain, Purva, Donald Szlosek, Serge Korjian, et al.. (2016). Abstract 19325: Betrixaban Reduces the Burden of Multiple Symptomatic Venous Thromboembolic Events in the APEX Trial. 134. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mustafa Öztürk Breakdown of academic impact, for papers by Abdullah Alshehri Breakdown of academic impact, for papers by Thomas Bo Jensen Breakdown of academic impact, for papers by Bruce M. Psaty Breakdown of academic impact, for papers by Irene Chung Breakdown of academic impact, for papers by Þórarinn Guðnason Breakdown of academic impact, for papers by Tarık Kıvrak Breakdown of academic impact, for papers by Khendi White Solaru Breakdown of academic impact, for papers by Mohammad Keykhaei Breakdown of academic impact, for papers by KH Jöckel
Rankless by CCL
2026